← Evidence map

ArticleBlood2021

Degrading JAK2 in ALL by ruxolitinib-based PROTACs.

Stefan N Constantinescu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 34882211